Added to YB: 2026-01-21
Pitch date: 2026-01-19
EXOZ [neutral]
eXoZymes, Inc.
-8.42%
current return
Author Info
Company Info
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing.
Market Cap
$88.3M
Pitch Price
$10.51
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.12
P/E
-10.28
EV/Sales
N/A
Sector
Biotechnology
Category
growth
AlmostMongolian Annual Review+Portfolio Update - eXoZymes, Inc.
EXOZ (holding update): Biotech using AI for enzyme production; progressed with $3M NSF grant & NCT-X subsidiary targeting 2027 commercialization despite weak 2025 performance. No JV materialized yet. Poor rebranding hurt perception. Sold 1/3 at $13-16, added below $10 where CEO buys. Massive long-term potential but unclear timeline.
Read full article (2 min)